Established predictors of recurrent disease include factors related to tumour biology, such as preoperative prostate-specific antigen (PSA), pathological stage, differentiation, and lymph node involvement, as well as procedure-related factors such as the rate of positive surgical margins (PSM) [4], [5], [6]. The gene discussed is KLK3; the disease is neoplasm.